HAL Allergy B.V. today announced that it has included the first patient in its PHASE II dose range finding study.
No Comments »
Filed under: Pharmacy News
Robert Linhardt is working to forever change the way some of the most widely used drugs in the world are manufactured. In the journal Science, he and his partner in the research, Jian Liu, have announced an important step toward making this a reality. The discovery appears in the journal Science in a paper titled [...]
No Comments »
Filed under: Pharmacy News
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that it has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for NUCYNTA ER (tapentadol) extended-release tablets, an oral analgesic, for the management of neuropathic pain associated with diabetic peripheral neuropathy in adults.
No Comments »
Filed under: Pharmacy News
Avanir Pharmaceuticals, Inc. announced today that it has submitted an application to the European Medicines Agency seeking marketing authorization for NUEDEXTA (dextromethorphan HBr and quinidine sulfate) for the treatment of pseudobulbar affect.
No Comments »
Filed under: Pharmacy News
The introduction of new antibiotic regimes to tackle hospital-acquired infections, such as C. difficile, must take into account the possibility of increased infections following specific surgical procedures.
No Comments »
Filed under: Pharmacy News
According to a study which evaluated alternative models for the delivery of clozapine services, published by the Pharmacy Practice Research Trust (PPRT), there is scope to review the team configurations needed to deliver community services in a cost-effective manner and to provide opportunities for improving the services provided to patients.
No Comments »
Filed under: Pharmacy News
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced that poster P409 presented at the upcoming 2011 annual scientific meeting of the American College of Gastroenterology highlights the potential use of guanylate cyclase-C agonists to delay progression of colitis into colon cancer.
No Comments »
Filed under: Pharmacy News
Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced financial results for the third quarter ended September 30, 2011 and provided an update on the U.S. Food and Drug Administration’s (FDA) approval of EXPAREL and the commercial strategy to support the product launch.
No Comments »
Filed under: Pharmacy News
Astex Pharmaceuticals, Inc., a pharmaceutical company dedicated to the discovery, development and commercialization of novel therapeutics, announced that it will present data on its novel, first-in-class direct acting antiviral agents (DAA) against Hepatitis C Virus (HCV) at the 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in San Francisco, [...]
No Comments »
Filed under: Pharmacy News
Pacira Pharmaceuticals, Inc. announces that the U.S. Food and Drug Administration (FDA) has approved EXPAREL 1.3% for administration into the surgical site to produce postsurgical analgesia.
No Comments »
Filed under: Pharmacy News
